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Aurein 1.2 is an antimicrobial and anticancer peptide isolated from an Australian frog. To improve our understanding of the mechanism of
action, two series of peptides were designed. The first series includes the N-terminal membrane anchor of bacterial glucose-specific enzyme IIA,
aurein 1.2, and a newly identified aurein 1.2 analog from human LL-37 (LLAA). The order of antibacterial activity is LLAANaurein 1.2NN the
membrane anchor (inactive). The structure of LLAA in detergent micelles was determined by 1H NMR spectroscopy, including structural
refinement by natural abundance 13Cα, 13Cβ, and 15N chemical shifts. The hydrophobic surface area of the 3D structure is related to the retention
time of the peptide on a reverse-phase HPLC column. The higher activity of LLAA compared to aurein 1.2 was attributed to additional cationic
residues that enhance the membrane perturbation potential. The second peptide series was created by changing the C-terminal phenylalanine (F13)
of aurein 1.2 to either phenylglycine or tryptophan. A closer or further location of the aromatic rings to the peptide backbone in the mutants
relative to F13 is proposed to cause a drop in activity. Phenylglycine with unique chemical shifts may be a useful NMR probe for structure–
activity relationship studies of antimicrobial peptides. To facilitate potential future use for NMR studies, random-coil chemical shifts for
phenylglycine (X) were measured using the synthetic peptide GGXGG. Aromatic rings of phenylalanines in all the peptides penetrated 2–5 Å
below the lipid head group and are essential for membrane targeting as illustrated by intermolecular peptide–lipid NOE patterns.
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Biological membranes are essential barriers for all living
cells, be they eukaryotes or prokaryotes. The importance of
cellular membranes in signal transduction, nutrient uptake, and
energy use has been firmly established. As a consequence,Abbreviations: NMR, nuclear magnetic resonance; APD, the antimicrobial
peptide database; DHPG, dihexanoylphosphatidylglycerol; D8PG, dioctanoyl
phosphatidylglycerol; D10PG, didecanoyl phosphatidylglycerol; DQF-COSY,
double-quantum filtered correlation spectroscopy; DSS, 2,2-dimethyl-silapen-
tane-5-sulfonate sodium salt; HSQC, heteronuclear single quantum coherence;
LLAA, the LL-37-derived aurein 1.2 analog; MPP, membrane perturbation
potential; NOE, nuclear Overhauser effect; NOESY, nuclear Overhauser
enhancement spectroscopy; PGs, phosphatidylglycerols; rmsd, root mean square
deviation; SDS, sodium dodecyl sulfate; TOCSY, total correlation spectroscopy
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doi:10.1016/j.bbamem.2006.03.032damage to cell membranes could be lethal. Antimicrobial pep-
tides are a class of molecules that are believed to kill microbes
by targeting cellular membranes, thereby rendering it difficult
for bacteria to develop drug resistance [1–4]. The great potential
of these “natural antibiotics” to be developed into novel the-
rapeutics is of long-standing interest to many laboratories
around the world as well as this special issue of Biochim.
Biophys. Acta. Of note, volume 1462 of the same journal
published in 1999 was also dedicated to antimicrobial peptides.
At present, more than five hundred antimicrobial peptides of
natural origin have been documented in several databases [5–7].
According to the antimicrobial peptide database (APD) [6], an
antimicrobial peptide may have a net charge of positive, zero, or
negative. Currently, the focus has primarily been on cationic
peptides owing to their preference for anionic bacterial mem-
branes [1–4]. To facilitate the potential use of cationic antimicro-
bial peptides as novel antibiotics, continuing studies are in
progress with the goal of elucidating the mechanism of their
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lecture for the symposium on “Membrane Biophysics of Anti-
microbial Peptides” held at the University of Michigan during
September 25–26, 2005, we have developed a set of tools for
structure and activity studies of these interesting peptides, in-
cluding the APD [6], a structural refinement method [8], a novel
membrane-mimetic model [9–11], the membrane perturbation
potential (MPP) model [8], the F-probe (i.e., the use of phenyl-
alanines as a probe for membrane penetration) [8], and a bacterial
expression system for antimicrobial peptides [12]. Some of these
developments have been highlighted in our review article [13].
In this study, we chose aurein 1.2 as a model peptide for two
reasons. First, aurein 1.2 from the Australian Bell Frog Lithoria
aurea [14] shows sequence homology to themembrane anchor (15
residues at the N-terminus, sequence in Table 1) [15] of the
glucose-specific enzyme IIA from Escherichia coli [8]. Second,
aurein 1.2 also shows sequence homology to a portion of the
peptide sequence of humanLL-37 (sequence is LLGDFFRKSKE-
KIGKEFKRIVQRIKDFLRNLVPRTES). Clearly, the spacing
between F17 and F27 in human LL-37 is identical to that between
F3 and F13 in aurein 1.2. Further, a greater sequence similarity
was achieved by reversing the sequence of the segment corres-
ponding to residues 17–29 of LL-37 (in Table 1, identical residues
are in black and semi-conserved residues relative to aurein 1.2 are
underlined). This LL-37-derived aurein 1.2 analog is hereinafter
referred to as LLAA (Table 1). Here we report the three-dimen-
sional structure of LLAA and its interaction with dioctanoyl
phosphatidylglycerol (D8PG). The sequence similarities, ranging
from the bacterial membrane anchor, to an amphibian antimicro-
bial peptide, to a peptide derived from human LL-37, allow us to
better understand the differences in antibacterial activity of these
peptides.
To provide additional insight into the critical F13 of aurein
1.2 [14], we also changed the C-terminal phenylalanine to
phenylglycine or tryptophan. Although phenylalanine and phe-
nylglycine differ only by a CH2 unit, phenylglycine shows
unique chemical shifts, potentially useful for structure and ac-
tivity studies of antimicrobial peptides. For this purpose, we
provide a set of random-coil chemical shifts for phenylglycine
(X) measured using the peptide template GGXGG. Our work
indicates that it is an advantage to combine the use of deuterated
SDS and protonated short chain PGs for high-resolution NMR
studies of antimicrobial peptides.
2. Materials and methods
2.1. Materials
All peptides (N95% purity) were synthesized and purified by Genemed
Synthesis (San Francisco, CA). Deuterated SDS (N99%) was obtained from
Cambridge Isotope Laboratories (Andover, MA). Protonated D8PG (N98%) was
purchased from Avanti Polar Lipids (Alabaster, AL). Chloroform was removed
from phospholipids under a stream of nitrogen gas followed by evaporation
under vacuum overnight. D8PG and SDS were used without further purification.
2.2. Antibacterial assay
The antibacterial activity of the peptides was analyzed using the standard
microdilution approach [8]. In brief, a small culture of E. coli strain K12 3000was grown overnight. A fresh culture was inoculated with a small aliquot of the
overnight culture and incubated at 37 °C until the culture reached the loga-
rithmic stage (A600 ∼0.5, 9×108 cells/ml). The culture was then diluted to A600
∼0.001 and partitioned into a 96-well plate with ∼106 cells per well (90 μl
each). Then, 10 μl aliquots of the peptide at different concentrations (three
assays for each) were added to the cultures, allowing the minimum inhibition
concentration (MIC) to be measured. The plate was then further incubated
overnight (∼16 h) at 37 °C and read on an Ultra Microplate Reader at 620 nm
(Bio-TEK Instruments).
2.3. Analytical reverse-phase HPLC
The retention time of each peptide was measured on an ISCO HPLC system
equippedwith aVydacC18 reverse-phase column (250×4.6mm). The peptidewas
eluted with a linear gradient of acetonitrile (containing 0.1%TFA) from 5% to 95%
at a flow rate of 1 ml/min. Peptides were detected by UVabsorbance at 215 nm.
2.4. NMR spectroscopy
The peptide concentration was∼2 mM in 0.6 ml of aqueous solution of 90%
H2O/10%D2O. The pH of each sample was adjusted by using microliter aliquots
of HCl or NaOH solution and measured directly in the 5-mm NMR tube with a
micro-pH electrode (Wilmad-Labglass). Based on titrations, a peptide/SDS
molar ratio of 1:40 and a peptide/D8PG ratio of 1:5 were used.
All NMR data were collected at 25 °C on a Varian INOVA 600 MHz NMR
spectrometer equipped with a triple-resonance cold probe with a Z-axis gradient.
NOESY spectra [16] were acquired at mixing times of 50 and 100 ms.
Additional NOESY spectra at 150 and 200 ms were collected to view the NOE
buildup as a function of mixing time. TOCSYexperiments were performed with
a mixing time of 75 ms using a clean MLEV-17 pulse sequence [17,18].
Typically, 2D homonuclear spectra were collected with 512 increments (16–32
scans each) in t1 and 2 K complex points in t2 time domains using a spectral
width of 8510.6 Hz in both dimensions with the 1H carrier on water. The water
signal was suppressed byWATERGATE [33] in the case of NOESYand TOCSY
and by low power presaturation during relaxation delay for the DQF-COSY
experiment [19]. Natural abundance HSQC spectra [20] involving either 15N or
13C were also collected by placing the 1H, 15N, and 13C carriers at 4.77, 118.27,
and 36.37 ppm, respectively. For the 15N (spectral width 2,200 Hz) and aliphatic
13C (spectral width 12,000 Hz) dimensions, 30 increments (128 scans) and 80
increments (256 scans) were collected, respectively.
NMR data were processed on a Silicon Graphics Octane workstation (SGI)
using the NMRPipe software [21]. The data points in the indirect dimension
were doubled by linear prediction for HSQC spectra. Time domain data were
apodized by a 63 ° shifted squared sine-bell window function in both dimen-
sions, zero-filled prior to Fourier transformation to yield a data matrix of
2 K×1 K. To prevent potential interaction of anionic DSS with cationic peptides
[9], the proton chemical shifts of the peptide were referenced to the water signal,
which in turn was referenced to internal DSS at 0.00 ppm. 15N and 13C chemical
shifts were referenced based on the ratios recommended by IUPAC [22].
NMR data were analyzed with the program PIPP [23]. The peptide proton
signals were assigned using standard procedures [24] based on 2D TOCSY,
DQF-COSY, and NOESY spectra. Natural abundance 15N, 13Cα, and 13Cβ
chemical shifts of the micelle-bound peptides were assigned on the basis of the
known proton chemical shifts [13].
2.5. Structure calculations
Three-dimensional structures of peptide LLAA in deuterated SDS micelles
at pH 4.4 and 25 °C were calculated based on both distance and angle restraints
by using the simulated annealing protocol in Xplor-NIH [25]. The distance
restraints were obtained by classifying the NOE cross-peak volumes into strong
(1.8–2.8 Å), medium (1.8–3.8 Å), weak (1.8–5.0 Å), and very weak (1.8–6.0
Å) ranges. The distance was calibrated on the basis of the typical NOE patterns
in an α helix [24]. Peptide backbone restraints were obtained from the TALOS
[26] analysis of sets of heteronuclear chemical shifts, including 1Hα, 13Cα, 13Cβ,
and 15N. A broader range (±20 °) than predicted was allowed for each angle in
structural calculations. The side-chain χ1 angles were derived from a short-
mixing-time NOESY spectrum (50 ms) [27]. A covalent peptide structure with
Table 1
Peptide sequences, properties, and antibacterial activity of aurein 1.2 analogs
Peptide Amino-acid sequence Number of K/R tRP
a (min) % Helix b MIC c (μM)
LLAA RLFDKIRQVIRKF 5 30.8 97 20
Aurein 1.2 GLFDIIKKIAESF 2 43.0 95 75
F13X-aurein 1.2 GLFDIIKKIAESX 2 38.3 100 160
F13W-aurein 1.2 GLFDIIKKIAESW 2 40.5 97 320
Membrane anchor GLFDKLKSLVSDDKK 4 29.5 64 inactive
a Retention time on a reverse-phase column of HPLC (see Methods) as a measure of hydrophobicity [38,39].
b Helix percentage was calculated based on the average Hα secondary shifts of the peptide divided by 0.35 [40]. The data for the bacterial membrane anchor and
aurein 1.2 were taken from ref. [8]. For the F13X mutant, the helicity was found to be 115%. This helicity offshoot may be attributed to the ring current effect.
Assuming the ring current effect of X13 caused an upfield shift of 0.7 ppm for the Hα of A10 (see the text), the helicity is reduced to 100%. Thus, the helixity of the
F13X mutant in this Table should be treated as an estimation.
c Minimum concentration at which E. coli growth is completely inhibited. The bacterial membrane anchor is not toxic at the highest concentration we used
(0.32 mM) [8]. The peptides were quantified by Waddell's method [41]. In this method, the peptide concentration (in mg/ml) was estimated based on the difference in
UV absorbance at 215 and 225 nm multiplied by 0.144.
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structure. The peptide structural template was also amidated at the C-terminus.
In total, 100 structures were calculated. An ensemble of 20 structures with the
lowest total energy was chosen for structural analysis. This final ensemble of
accepted structures also satisfies the following criteria: no NOE violations
greater than 0.50 Å, rmsd for bond deviations from ideality less than 0.01 Å, and
rmsd for angle deviations from ideality less than 5 °. The coordinates of the LL-
37-derived aurein 1.2 analog have been deposited with the Protein Data Bank
(PDB entry 2F3A).3. Results
3.1. Solution structure of LLAA bound to micelles
To provide insight into the mechanism of action, three-
dimensional structures of antimicrobial peptides in bacterial
membranes are essential. Direct structural determination of anti-
microbial peptides in bacterial membranes at atomic resolution is
challenging. Consequently, structural data of antimicrobial pep-
tides (and membrane proteins) are currently obtained in mem-Fig. 1. The fingerprint region of the NOESY spectrum (mixing time 100 ms) of LL-
ratio of 1:40, pH 4.4, and 25 °C. The HN–Hα NOE cross peak for each residue is la
signal assignments. Also labeled are key inter-residue NOE cross peaks of (i, i+3) a
pattern was observed at pH 5.4 as well.brane-mimetic models, including organic solvents, detergent
micelles, bicelles, lipid vesicles, and lipid bilayers (reviewed in
ref. [13]). While organic solvents are convenient to use, they are
only distantly related to the lipid bilayer structure of biological
membranes. Lipid vesicles are not convenient for solution NMR
studies due to their large size, leading to broad NMR lines. Lipid
bilayers are regarded as the best models for solid-state NMR
studies (see other papers in this issue). Bicelles (bilayeredmicelles)
are a newer model that has found use in both solution and solid-
state NMR studies. The application of bicelles in solution NMR
studies, nevertheless, is very limited. Detergent micelles have been
most widely utilized as a membrane-mimetic model for solution
NMR studies. Micelles are relatively simple to make and have
favorable tumbling rates in solution. Further, there are deuterated
versions of detergents commercially available for both SDS and
dodecylphosphocholine (DPC).
Because of the preference of cationic antimicrobial peptides
for anionic lipids, we have explored the use of PGs as an
alternative bacterial membrane-mimetic model [9–13]. Our37-derived aurein 1.2 analog in sodium dodecyl sulfate (SDS) at a peptide/SDS
beled using the single-lettered amino-acid code. The constructs show sequential
nd (i, i+4) types, indicative of a helical structure. A similar NOE connectivity
Fig. 2. The Hα (A), Cα (B), and Cβ (C) secondary shift plots for the micelle-
bound LL-37-derived aurein 1.2 analog (LLAA). Secondary shifts are the
chemical shift differences between the measured and random-coil shifts. The
random-coil shifts used are Hα from ref. [24] and Cα and Cβ from ref. [29].
Heteronuclear chemical shifts for LLAAwere obtained from natural abundance
2D correlated spectra [20]. All these plots suggest a helical structure for residues
2–12 of peptide LLAA.
Fig. 3. Structure of the LL-37-derived aurein 1.2 analog (LLAA) bound to SDS
micelles at pH 4.4 and 25 °C determined by solution NMR spectroscopy [24]
and refined by chemical shift derived backbone angles [8]. Shown are the
backbone (A), backbone and side chains (B) of LLAA with residues 2–12
superimposed, and a ribbon diagram for a representative structure with side
chains selectively labeled.
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dichroism spectra of the bacterial membrane anchor from the N-
terminus of E. coli IIAGlc are identical in dioleoylphosphati-
dylglycerol or a mixture of dioleoylphosphatidylglycerol and
dioleoylphosphatidylethanolamine, mimicking the E. coli
membranes [15]. High-resolution NMR spectra were obtained
for this peptide in short chain PGs. The peptide was found to
adopt a three-turn amphipathic helical structure in short chain
PGs [9,10]. While the effect of chain length (six to 12) of SDS-
like detergents on the helix length of the peptide was evident,
PG acyl chain length ranging from six to 10 carbons (longer
chain PGs form lipid bilayers) showed little effect, indicating
the robustness of short chain PGs. Translational diffusion co-
efficients of the peptide–lipid complexes reduced with the
increase of PG chain length, indicative of an increase in the size
of the complex [10,11]. We chose dioctanoylphosphatidylgly-
cerol (D8PG) in this study because NMR spectra of the peptide
in the bound state can be obtained at a lower lipid/peptide molar
ratio compared to dihexanoylphosphatidylglycerol (DHPG). At
a lower lipid concentration, the interference of strong signals
from protonated PGs with the NMR spectra of the peptide is
reduced [10]. In several cases, we have performed parallel NMR
studies of the peptides in both short chain PGs and SDS. The 3D
structures of those peptides are very similar in the two en-
vironments, indicating that SDS mimics short chain PGs well in
these particular cases [9–13]. As a consequence, we have uti-lized deuterated SDS micelles for optimal structural determi-
nation of LLAA (sequence in Table 1) and protonated D8PG for
investigating peptide–lipid interactions.
Fig. 1 shows a portion of the NOESY spectrum of LLAA
bound to SDS micelles. The peptide signals were assigned using
standard procedures [24] based on TOCSY, NOESY, and DQF-
COSY spectra. Briefly, amino acid spin systems of LLAAwere
identified in the TOCSY spectrum followed by connecting the
amino acids using the NOESY spectrum. Complete assignments
of longer side chains were corroborated by the DQF-COSY
spectrum.
To identify secondary structures in this novel peptide,
secondary shifts [28] of α-protons for each residue were cal-
culated (see Fig. 2). With heteronuclear chemical shifts avail-
able, we also calculated 13C secondary shifts. Secondary shifts
are defined as the chemical shift differences between the mea-
sured and the random-coil shifts. A row of negative values
(upfield shifts) in the plots for Hα (Fig. 2A) and Cβ (Fig. 2C)
and a continued train of positive deviations (downfield shifts)
Fig. 4. Potential surfaces for the LL-37-derived aurein 1.2 analog (A and B), aurein 1.2 (C and D), and the E. coli membrane anchor from the N-terminus of the
glucose-specific enzyme IIA involved in phosphoryl transfer coupled to glucose transport (E and F). Panels B, D, and F are end-on views of panels A, C, and E. The
coordinates of aurein 1.2 (PDB entry 1VM5) and the membrane anchor (PDB entry 1O53) were taken from refs. [8] and [9], respectively. For a fair comparison, the
structure of the bacterial membrane anchor was refined here using chemical shift derived backbone angles covering residues L2–L9 [8]. Additional disordered residues
K14–K15 (Table 1) were not included in the structural refinement. The figure was generated by using MOLMOL [30].
Table 2
Comparison of the chemical shifts (in ppm) of the aromatic rings of the LL-37-
derived aurein 1.2 analog (LLAA) in SDS and D8PG
Environment F3 Hδ F3 Hε F13 Hδ F13 Hε
SDS a 7.23 7.15 7.43 7.30
D8PGb 7.23 7.12 7.41 7.26
a Measured at a peptide/SDS molar ratio of 1:40, at pH 4.4 and 25 °C.
b Measured at a peptide/D8PG molar ratio of 1:5, at pH 7.0 and 25 °C.
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residues 2–12 of LLAA were predicted to be helical. The
helicity of the peptide, based on the Hα secondary shifts, is 97%
(Table 1). In Fig. 1, (i, i+3) and (i, i+4) types of NOE cross
peaks between Hα and amide protons are selectively labeled,
indicative of an α-helical structure [24]. Therefore, the secon-
dary structure of LLAA predicted by chemical shifts is in accord
with the NOE pattern.
The three-dimensional structure of LLAA was determined
based on NOE-derived distance restraints. In total, 191 distance
restraints (72 intra-residue, 60 sequential, and 59 short-range)
were obtained. Note that the phases of cross peaks for F3, D4,
and F13 were slightly influenced by a default water flipback
pulse in the Varian 2D wgnoesy pulse sequence. Because these
intra-cross-peaks were not included in structural determination,
these peaks had no impact on the accuracy of the 3D structures.
The structure was further refined using heteronuclear chemical
shifts [8]. One approach is to convert these shifts into backbone
angles by using TALOS [26]. An ensemble of 20 structures withthe lowest energy was selected by the accept.inp program. A
backbone view of the ensemble of LLAA with residues 2–12
superimposed is given in Fig. 3A. The rms deviations for
superimposing the backbone, heavy, and all atoms of residues
2–12 of the peptide are 0.19, 0.99, and 1.29 Å, respectively. To
further illustrate the quality of the structure, the side chains of
the peptide are displayed in Fig. 3B. The hydrophobic side
chains (e.g., F3 and F13) superimpose well, indicating good
precision. In contrast, the ends of the long cationic side chains
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due to both motion and a lack of NOE restraints in those
regions. It is clear that the hydrophobic side chains are clustered
on one side of the structure (Fig. 3C), while the hydrophilic side
chains are located on the opposite side. Consequently, the
structure of peptide LLAA is amphipathic. Although TALOS
[26] predicted that residues 2–12 are helical, only residues 4–12
of LLAAwere found to be helical according to both MOLMOLFig. 5. (A) Chemical structure of dioctanoyl phosphatidylglycerol (D8PG). (B) Interm
1) and didecanoyl phosphatidylglycerol (D10PG) at pH 5.4. (C) Intermolecular NOE
and D8PG at pH 7. Intermolecular NOESY spectra were recorded at a peptide/lipid m
selectively labeled with peptide resonances at the top of the panels and lipid signals[30] and PROCHECK [42] analysis of the structural ensemble.
The absence of a one-turn helical ribbon at the N-terminus of
the peptide might result from the absence of some helical
restraints from residue L2 to both K5 and I6 due to spectral
overlap (Fig. 1). Nevertheless, 95% of the residues of LLAA are
in the most favored region of the Ramachandran plot and 5% are
located in the additional allowed region [42], indicating the
overall high quality of the structures.olecular NOE cross peaks between F3 of the bacterial membrane anchor (Table
cross peaks between F3 and F13 of the LL-37-derived aurein 1.2 analog (Table 1)
olar ratio of 1:5 and 25 °C. For clarity, only intermolecular NOE cross peaks were
by the peaks.
Fig. 6. A cartoon view of the LL-37-derived aurein 1.2 analog (in cyan and
viewed from the N-end of the structure) in complex with D8PG. Two D8PG
molecules (in gold) were positioned in the vicinity of the aromatic rings of F3
and F13 based on intermolecular NOE observations (Fig. 5C). See the text for
additional details.
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The amphipathic helix of LLAA (Fig. 4A and B) would be
ideal for targeting bacterial membranes. To provide direct evi-
dence for the interaction of this cationic LL-37-derived peptide
with anionic lipids, we have also collected intermolecular
NOESY data [9,31]. Since the peptide is not isotopically
labeled, we focused our attention on relatively well-resolved
aromatic resonances [8,9]. Of note, the chemical shifts of the
aromatic rings of F3 and F13 of LLAA are remarkably similar
in SDS and D8PG micelles (Table 2), indicating their locations
in similar chemical environments. Fig. 5 shows the cross peaks
between aromatic resonances of LLAA and D8PG. To ap-
preciate these intermolecular NOE cross peaks, Fig. 5A also
presents the chemical structure of D8PG with atoms selectively
labeled. While both the acyl chains (C2–H, C3–H, (CH2)n, and
CH3) and the glycerol portions (α, β, γ) of the lipid interact
with F3, there is no NOE cross peak from F13 to the β proton of
D8PG (Fig. 5C), suggesting that F13 is immersed more deeply
into the lipid micelles than F3. Such an intermolecular NOE
pattern for F3 was first observed in the bacterial membrane
anchor (sequence in Table 1) bound to DHPG [9]. Similar
results were also observed for this peptide anchor in complex
with didecanoyl phosphatidylglycerol (D10PG) (Fig. 5B).
These observations indicate that F3 in either the bacterial
membrane anchor or LLAA interacts with lipids in a similar
manner.
Because the intensity of NOE cross peaks depends on dis-
tance, molecular motion, and mixing time [24,27], a qualitative
interpretation of intermolecular NOE data is warranted. Using
the intermolecular NOE cross peak between aromatic protons
and the C2–H of D8PG as an example, we observed normal
NOE buildups with an increase in mixing time, confirming that
these cross peaks are not derived from spin diffusion. In Fig.
5C, a one-dimensional slice for one of the C2–H of D8PG
(indicated by arrow) with the aromatic protons of both F3 and
F13 is shown. The NOE intensities of the δ- and ε-protons of
F13 with the C2–H of D8PG are more or less the same, in-
dicating that both protons are located approximately at a similar
depth in the lipid micelle (also see Fig. 6). However, the
intermolecular NOE intensity between the δ-protons of F3 and
C2-H protons of D8PG is stronger than that between the ε-
protons of F3 and the same C2-H protons, indicating that the
aromatic ring of F3 has inserted into the lipid micelles with the
ε-proton pointing down as shown in the end-on view of the
structure of LLAA (Fig. 6). Therefore, the orientations of aro-
matic rings implied by intermolecular NOE cross peaks are
consistent with the structure determined in detergent micelles
(Fig. 3). The agreement between the intermolecular NOE cross
peak patterns and the micelle-bound structure of LLAA further
justifies the usefulness of aromatic phenylalanines as a probe
(i.e., the F-probe) for membrane penetration of antimicrobial
peptides [8]. Consequently, a model for LLAA in complex with
D8PG is represented in Fig. 6. In the model, both aromatic rings
are placed slightly below lipid head groups because the NOE
cross peaks to acyl chains are stronger than those to lipid head
groups (Fig. 5).3.3. Structure and activity relationship of LLAA, aurein 1.2,
and the E. coli membrane anchor
Antibacterial assays revealed that LLAA is more toxic to E.
coli than aurein 1.2, which, in turn, is more toxic than the
bacterial membrane anchor (Table 1). To explain the activity
differences of this series of aurein 1.2 analogs, we use the 3D
structure-based MPP model [8] because a single parameter such
as the number of positively charged residues, helicity, or hy-
drophobicity (as measured by HPLC retention time) does not
correlate well with the order of antibacterial activity of the
peptides in Table 1. According to the MPP model [8], a po-
sitively charged peptide is attracted to the negatively charged
membrane surface via electrostatic interaction followed by
penetration into the membrane through hydrophobic interac-
tion. The MPP is determined by a combination of hydropho-
bicity and charges. In the case of our previously studied aurein
1.2 (Fig. 4C and D) and the bacterial membrane anchor (Fig. 4E
and F), both peptides contain two cationic side chains in their
membrane-targeting helical domains. The difference in their
antibacterial activity was ascribed to the narrower and shorter
hydrophobic surface of the membrane anchor (Fig. 4F) than
aurein 1.2 (Fig. 4D). Indeed, the membrane-binding hydropho-
bic surface areas of the bacterial membrane anchor and aurein
1.2 are 586.9 and 772.9 Å2 (average values of 20 structures),
respectively. Interestingly, the reverse-phase HPLC retention
time of the bacterial membrane anchor (29.5 min) is shorter than
that of aurein 1.2 (43 min), indicating that the HPLC retention
time of the peptide may be related to the hydrophobic surface
for micelle binding. The narrow hydrophobic surface of the
cationic membrane anchor may explain its ability to associate
with anionic lipids, but not with zwitterionic phosphocholines
Table 3
Random–coil chemical shifts for phenylglycine (X) measured using the
GGXGG peptide template (4.4 mM) at pH 5.4 and 25 °C
Nucleus HN, 15N Hα, 13Cα Aromatic a
δ (ppm) 8.81, 123.64 5.47, 61.23 1H, 7.44; 13C, 130.41, 131.96
a Chemical shifts were obtained from a set of 2D NMR experiments, including
TOCSY, (1H, 15N) HSQC, (1H, 13C) HSQC, and NOESY. The γ and δ carbon
shifts were not distinguishable based on these experiments.
Fig. 7. Comparison of the fingerprint regions of the DQF-COSY spectra of
aurein 1.2 (A) and its F13X analog (B) bound to SDS micelles at pH 5.4 and
25 °C. X stands for phenylglycine. The Hα of phenylglycine at 5.2 ppm (B) is
well separated from the other α-protons of the peptide that adopts a helical
conformation (see text). For random-coil chemical shifts of phenylglycine, see
Table 3.
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coli, this peptide may contain the minimal requirement for
targeting negatively charged bacterial membranes [9]. The ave-
rage exposed hydrophobic surface for the ensemble of struc-
tures of LLAA is 636.1 Å2 (Fig. 4B), which is only slightly
larger than that of the bacterial membrane anchor (Fig. 4F).
Correspondingly, the retention time of peptide LLAA on a
reverse-phase HPLC (30.8 min) is also only slightly longer than
that of the bacterial membrane anchor (29.5 min). Both the
exposed hydrophobic surface and the HPLC retention time
indicate that LLAA possesses the minimal hydrophobic re-
quirement for targeting bacterial membranes. Consequently, the
higher antibacterial activity of LLAA than either aurein 1.2 or
the bacterial membrane anchor cannot be attributed to the
difference in hydrophobicity, but to the additional cationic
residues (Fig. 4B), which raised the MPP of the peptide for
perturbing negatively charged bacterial membranes.
3.4. An aurein 1.2 analog generated by deleting a methylene
group from the last phenylalanine
The original study of aurein 1.2 already pointed to the
importance of F13 since changing F13 to isoleucine eliminated
the anticancer activity [14]. Likewise, we demonstrated that thenon-toxic bacterial membrane anchor [15] could be converted to
an antimicrobial peptide by changing D13 to F13 [8]. To better
understand the role of F13 in governing the structure and
activity of aurein 1.2, we have designed additional mutants with
more conservative changes. In one of the mutants, only the β-
methylene group (CH2) was eliminated from F13 of aurein 1.2;
in other words, F13 was changed to phenylglycine (X). Anti-
bacterial assays of this mutant indicated that the methylene
deletion caused a reduction in activity (higher MIC in Table 1)
relative to aurein 1.2.
To understand the structural basis for the activity change, we
also analyzed the F13X mutant in SDS micelles by NMR
spectroscopy. A combined 1H and 15N backbone chemical shift
perturbation [37] of aurein 1.2 as a result of the F13Xmutation is
plotted in Fig. 8A. Apparently, this mutation caused more than
100-Hz perturbations only to residues 10–13, indicative of a
local effect. Indeed, the calculated helicity of the mutant based
on Hα chemical shifts is comparable to that of aurein 1.2
(Table 1). Further, there are also NOE cross peaks from the
aromatic ring of X13 to the hydrophobic side chains of I9 and
A10, indicating a hydrophobic packing similar to that observed
for aurein 1.2 [8]. However, the Hα proton of A10 shifted from
4.04 ppm (Fig. 7A) in aurein 1.2 to 3.3 ppm (Fig. 7B) in the
F13X mutant. This 0.7 ppm shift of the Hα of A10 may be
related to the ring current effect of X13 [32]. Indeed, both the γ
and δ protons of the X13 aromatic ring showed NOE cross peaks
of medium intensity with the Hα of A10, indicating a direct
location of the aromatic ring underneath the Hα of A10. Thus,
the reduced activity of the F13X analog may result from the
packing of the aromatic ring of X13 toward the peptide backbone
(as evidenced by the ring current effect). This upper location of
the X13 ring also caused a decrease in the hydrophobicity of the
peptide. The retention time of the F13X mutant on the reverse-
phase HPLC column is 38.3 min compared to 43 min of aurein
1.2 (Table 1). This may explain the reduced activity of the F13X
aurein 1.2 mutant.
It is also noteworthy that the Hα proton of X13 appears at
5.2 ppm (Fig. 7B) while that of F13 resonates at 4.49 ppm (Fig.
7A). Hence, the Hα proton of X13 is well separated from the
rest of the α-protons of this helical peptide, which are all above
the water at 4.77 ppm (Fig. 7B). This unique chemical shift of
the Hα of phenylglycine in a helical peptide should be useful for
resolving ambiguous assignments when there are multiple
phenylalanines in a single antimicrobial peptide. Indeed, ∼70
antimicrobial peptides in the APD contain three or more phe-
nylalanines in their sequences [6]. To facilitate the use of this
phenylalanine analog in future NMR studies, we also obtained a
set of random-coil chemical shifts for phenylglycine (X) using
Fig. 8. Chemical shift perturbations of aurein 1.2 as a result of the change of F13
to phenylglycine (A) or tryptophan (B). Natural abundance HSQC spectra of the
peptides [37] were collected in the presence of SDS micelles, pH 5.4 and 25 °C.
The chemical shift perturbation was calculated by taking the square root of the
combined 1H and 15N chemical shift changes (in Hz). The data for aurein 1.2
were taken from ref. [8].
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the Hα of phenylglycine at 5.47 ppm enables the calculation of
its secondary shift. For instance, the secondary shift of the Hα
of X13 of the F13X mutant is −0.27 ppm, indicative of an
upfield shift.
3.5. The F13W analog of aurein 1.2
While the F13X mutation caused an upward movement of the
C-terminal aromatic ring toward the peptide backbone, we also
made the change of F13 to tryptophan (F13W) so that the six-
membered aromatic ring is further away from the peptide back-
bone than that of F13. Surprisingly, this mutation essentially
eliminated the bioactivity of the peptide (MIC=320 μM in
Table 1), although the structural perturbation of this mutation is
local according to the chemical shift perturbation plot in Fig. 8B.
Therefore, the helical structure of the F13Wmutant is retained as
also supported by continuous (i, i+3) and (i, i+4) types of NOE
cross peaks covering residues 2–13. To provide evidence for the
approximation of the aromatic rings to the peptide backbone, we
measured the intensity of the NOE cross peak from each aromatic
ring to the Hα of A10. Tominimize potential intensity differences
between the spectra of different peptides, the NOE ratio between
theW13Hε3 (or its equivalent F13 Hδ in aurein 1.2 or X13Hγ in
the F13Xmutant)-A10 Hα cross peak and the HN-Hα cross peak
of A10 was taken. The ratio involving W13 Hε3 is smallest,
followed by F13 Hδ, and X13 Hγ protons (which is only slightlylarger than F13 Hδ), indicating that the distance of these aromatic
protons to A10 Hα is approximately W13 Hε3NNF13 HδNX13
Hγ. In other words, the phenylglycine aromatic ring of the F13X
analog is closest to the peptide backbone (also see above, the ring
current effect), while the six-membered-ring of the Trp residue of
the F13Wanalog is farthest from the peptide backbone. Therefore,
a closer (the F13X mutation) or further (the F13W mutation)
location relative to the peptide backbone of the C-terminal aro-
matic ring of the aurein 1.2 analogs reduces the ability of the
peptide to kill bacteria. The sensitivity of the toxicity of aurein 1.2
to the position of the C-terminal aromatic ring (relative to the Hα
of A10) further indicates that a proper location of the C-terminal
phenylalanine is critical for the antibacterial activity of the pep-
tide. Perhaps, nature has optimized this aromatic ring for the
benefit of the Australian Bell Frogs.
3.6. Comparison of peptide–lipid interactions in the two series
of the aurein 1.2 analogs
The interactions of the F3 aromatic rings of all these aurein
1.2 analogs with D8PG are more or less similar to those ob-
served for the bacterial membrane anchor (Fig. 5B). For F13 in
aurein 1.2, W13 in the F13W analog, and X13 in the F13X
analog, the intermolecular NOE cross peaks from these aro-
matic rings to the C2-H protons of D8PG are much weaker or
barely detectable, although there are strong NOE cross peaks to
the (CH2)n protons. In contrast, the intermolecular NOE cross
peaks from F13 of LLAA to the C2-H of D8PG are clear (Fig.
5C). Therefore, the F13 in aurein 1.2 and the equivalent
aromatic rings in its F13 mutants all insert into the lipid micelles
more deeply than F13 in LLAA. A deeper penetration of those
aromatic rings appears to be related to the higher hydrophobic-
ity of aurein 1.2 and its F13 mutants than LLAA (see the HPLC
retention times in Table 1). Since the F13 mutants are not as
active as aurein 1.2, it is the proper penetration, rather than a
simple deep penetration, that determines the activity of the
peptide. It appears to be general in these aurein 1.2 analogs that
F13 adopts a slightly deeper location in lipid micelles than F3
(e.g., Fig. 5C). The different locations of the aromatic phenyl-
alanines in the same peptide further support the uniqueness of
each aromatic ring in interactions with membranes. We propose
that a proper penetration of the aromatic rings ensures the
membrane perturbation potential of an antimicrobial peptide.
4. Discussion
We have identified a novel aurein 1.2 analog from human
LL-37 (LLAA) based on the similarity in the spacing of two
aromatic residues. This 13-residue peptide also adopts a helical
conformation in membrane-mimetic micelles (Fig. 3). The
structural similarity of both bacterial membrane anchor [9] and
aurein 1.2 [8] in SDS and short chain PGs micelles adds further
confidence in the use of deuterated SDS micelles for the struc-
ture determination of LLAA. Actually, the aromatic rings of F3
and F13 of LLAA have nearly identical chemical shifts in SDS
micelles or D8PG lipid micelles (Table 2), indicating the lo-
cations of the aromatic rings in a similar environment.
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mination of antimicrobial peptides, protonated short chain PGs
enable the investigation of peptide–lipid interactions by sol-
ution NMR [13]. Indeed, we provided direct evidence for the
association of aromatic rings of the LL-37-derived aurein 1.2
analog with D8PG (Fig. 5). We also showed that peptide–lipid
intermolecular NOE patterns contain information about the
penetration depth and orientation of the aromatic rings of phe-
nylalanines in a lipid environment. Interestingly, a previous
solid-state NMR study of a membrane-targeting peptide in a
lipid bilayer arrived at a similar conclusion [34]. These authors
proposed a location of the aromatic ring of phenylalanines in the
vicinity of the acyl chains, on the basis of the strong NOE cross
peaks between the peptide and acyl chains. Their results are
consistent with the observation using spin labels that place the
aromatic ring 2–5 Å below the lipid head group. In our case,
only weak NOE cross peaks were observed from aromatic rings
to lipid head groups and the NOE cross peaks to acyl chains are
intense (Fig. 5). Therefore, the aromatic rings of F3 and F13 of
peptide LLAA must be located underneath the head groups of
D8PG as depicted in Fig. 6. Similar locations of aromatic rings
of phenylalanines observed by magic-angle spinning solid-state
NMR in lipid bilayers [34] and by solution NMR in lipid
micelles [8,9] further illustrate the usefulness of short chain PGs
in providing insights into peptide–lipid interactions [10,13],
even though the membrane-targeting peptides in the two studies
differ. It appears that the penetration depth of aromatic phe-
nylalanines is related to their positions in the peptide as well as
the peptide hydrophobicity as measured by HPLC. Since ∼67%
of the antimicrobial peptides in the APD [6] possesses at least
one phenylalanine, this aromatic residue, and perhaps other
aromatic residues as well [35], may serve as a useful probe for
membrane penetration and binding of membrane-targeting
peptides.
The importance of F13 of aurein 1.2 in targeting the bacterial
membrane and killing bacteria is further supported by our
mutagenesis data. An alteration of F13 to either phenylglycine
or tryptophan reduces the toxicity of the peptide toward E. coli.
Since the overall helical structure is maintained in these mutants
(Fig. 8), the activity change may result from different locations
of the last aromatic residue (F13, W13 and X13) relative to the
peptide backbone. The subtle change from phenylalanine to
phenylglycine (viz., only a CH2 group) may be useful as a
modulator for peptide design. Further, the unique chemical
shifts of phenylglycine (Table 3) may be employed as an aid for
NMR studies of antimicrobial peptides with multiple phenyla-
lanines (for examples, visit the APD [6]).
It is remarkable to find sequence homology among the bac-
terial membrane anchor, aurein 1.2, and a segment from human
LL-37 (Table 1). The membrane anchor of the glucose-specific
enzyme IIA of the bacterial phosphotransferase system is es-
sential for the terminal phosphoryl transfer of the E. coli signal
transduction pathway [9,15], while aurein 1.2 is a key antimi-
crobial peptide from an Australian frog [14]. LL-37 is the only
human antimicrobial peptide in the family of cathelicidins and is
essential for human defense against infection (for a review, see ref.
[36]). Since the bacterial membrane anchor is not toxic to E. coli,it serves as a useful control for a good understanding of the
activity of aurein 1.2, which became active by increasing its
hydrophobicity [8]. In turn, the bacterial membrane anchor and
aurein 1.2 set a ladder toward a better understanding of the activity
of the LL-37-derived aurein 1.2 analog. Because LLAA is as
hydrophobic as the bacterial membrane anchor (Table 1), the
higher activity of LLAA than aurein 1.2 is not due to a higher
hydrophobicity, but due to an increased number of positively
charged residues (Fig. 4). Thus, antibacterial activity of an anti-
microbial peptide could be augmented by an increase in either
hydrophobicity (e.g., from the anchor to aurein 1.2) or cationic
residues (e.g., from the anchor to LLAA). Such observations
further reinforce the usefulness of the structure-based MPP
model, which takes both hydrophobicity and charges into con-
sideration [8]. This work also lays the basis for quantifying the
membrane perturbation potential as more data accumulate (Table
1). The discovery of peptide sequences homologous to amphibian
antimicrobial peptide aurein 1.2 from bacteria and humans sug-
gests a useful sequence in nature could be utilized by a variety of
species for different or similar purposes by interacting with cel-
lular membranes and perhaps other targets as well.
Since sequence reversal had little effect on the activity of the
LL-37 core antimicrobial peptide corresponding to residues 17-
29 (see ref. [43]), the 3D structure (Fig. 3) as well as the results
on peptide–lipid interactions (Fig. 5) should also provide in-
sight into the mechanism of action of human LL-37. While we
have completed the structural determination of LL-37 fragments
using synthetic peptides [43] and are currently completing the
3D structure determination of intact LL-37 using isotope-la-
beled peptide purified from bacteria [12], Ramamoorthy and
colleagues have investigated the effect of LL-37 on lipid
bilayers by 2H, 31P, and 15N NMR [44,45]. Both 2H and 31P are
excellent probes in lipids that offer insight into structure and
dynamics of specific lipids as well as the lipid phase [13]. In the
presence of LL-37, a decrease in the quadrupolar splitting of 2H
along the acyl chain was found, indicating increased disorder in
lipid chains caused by the peptide [44]. Further, 31P NMR
indicates that LL-37 also changes the tilt or wobble of lipid head
groups. Another advantage of solid-state NMR is its capability
of determining the orientation of antimicrobial peptides in lipid
bilayers. Using 15N NMR and site-specific isotope labeling, the
putative helical structure of LL-37 was found to be oriented
parallel to the membrane surface [45]. Similar information was
obtained by solid-state NMR for several other antimicrobial
peptides, including magainin (from frog) [46] and its analog
MSI-78 [47], pardaxin from fish [48,49], protegrin-1 from pig
[50], and polyphemusin I from horseshoe crab [51]. Among
them, magainin, MSI-78, and pardaxin form helical structures
while protegrin and polyphemusin I form β-hairpin structures
(for representative structures of antimicrobial peptides, please
visit our web site at http://aps.unmc.edu/AP/main.html). In
several studies (e.g., refs. [49,51]), both solid-state and solution
NMR techniques have been utilized. Such a combined use of
NMR techniques takes advantage of the efficiency of solution
NMR in determining the structure of antimicrobial peptides and
the capability of solid-state NMR in providing additional lipid
information in lipid bilayers. The unique part of our
1213X. Li et al. / Biochimica et Biophysica Acta 1758 (2006) 1203–1214contribution in this study is both high-quality 3D structure and
invaluable direct evidence for peptide–lipid interaction. Be-
cause PGs are true lipids, our results obtained by solution NMR
should be more applicable to lipid bilayers. Of interest is that
both F3 (close to the N-terminus of the peptide LLAA) and F13
(at the C-terminus) show clear intermolecular NOE cross peaks
with D8PG (Fig. 5), depicting a picture (Fig. 6) for the first time
that the cationic amphipathic helix will be directly located on
the membrane surface to interact with anionic PG electronically,
with the aromatic rings (and other hydrophobic side chains)
penetrating into lipid bilayers via hydrophobic interactions,
thereby influencing lipid structure and dynamics detectable by
solid-state NMR [44,45]. In conclusion, a combined use of
solid-state and solution NMR [8,49,51] is able to provide details
on the mechanism of action of antimicrobial peptides at the
atomic level.
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